特发性颅内压增高症的血管内治疗:51例患者即刻与长期结果的回顾性分析
回顾性分析51例特发性颅内压增高症(IIH)合并静脉窦狭窄患者行支架置入治疗的安全性和疗效。88%患者视乳头水肿改善或消退,84%头痛改善或消退。中位随访49个月时48例造影中12例出现支架内狭窄或新发狭窄,其中8例需再治疗。
要点
- IIH合并静脉窦狭窄患者行支架置入技术成功率高且无严重并发症。
- 术后88%患者视乳头水肿改善或消退,84%头痛改善或消退。
- 中位随访49个月时48例造影中12例出现支架内狭窄或新发狭窄,8例需再治疗。
核心结论
- 静脉窦支架置入是IIH患者其他侵入性治疗(如视神经鞘开窗、脑脊液分流)的安全有效替代方案。
- 多数患者获得持续临床获益。
研究设计与样本
- 回顾性分析51例特发性颅内压增高症患者,中位年龄40岁,行静脉窦狭窄支架置入治疗。
- 临床表现为头痛者占74.5%,视觉模糊者占78.5%。
- 50/51例(98%)存在视乳头水肿,除1例外(98%)腰穿证实脑脊液开放压力升高。
- 所有患者均观察到静脉窦狭窄。
关键影像表现/征象
- 所有患者均存在静脉窦狭窄。
- 术后88%患者视乳头水肿改善或消退。
- 术后84%患者头痛改善或消退。
- 随访造影显示12例出现支架内狭窄或新发狭窄,其中8例需再治疗。
局限性
- 原文为回顾性分析。
- 随访造影仅在48例患者中进行,中位间隔49个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Idiopathic intracranial hypertension (IIH) is a disorder of increased intracranial pressure in the absence of any known causative factor. Sinus stenosis is common in these patients. Stenting of stenotic dural sinuses has gained popularity as a treatment option, since these stenoses may contribute to an obstruction of the venous return, and, thereby may contribute to IIH via an increase in venous sinus pressure. We evaluated the safety and efficacy of endovascular treatment in IIH with venous sinus stenosis.
METHODS: Fifty-one patients with IIH underwent stenting. Median age was 40 years. Clinical manifestation was headache in 74.5% of the patients and visual obscurations in 78.5%. Papilledema was present in 50/51 patients (98%), and lumbar puncture documented elevated CSF opening pressure in all but one patient (98%). Sinus stenoses were observed in all patients.
RESULTS: Endovascular treatment was successfully performed in all patients. There were no major complications encountered (i.e., live threatening or causing a deterioration of a patient's condition equivalent to mRS 3-6). Improvement or resolution of papilledema was observed in 88% of the patients, and 84% reported improvement or resolution of the headache. Follow-up angiographies were performed in 48 patients at a median interval of 49 months and demonstrated in stent-stenosis or a de novo stenosis in 12 patients, eight of them needed re-treatment.
CONCLUSION: Venous sinus stenting is a safe and effective alternative to other invasive treatments (e.g., optic nerve sheath fenestration, CSF diversion) in patients with IIH. The majority of patients have a persistent clinical benefit.
引用
- Aguilar-Pérez M, Martinez-Moreno R, Kurre W, et al. Endovascular treatment of idiopathic intracranial hypertension: retrospective analysis of immediate and long-term results in 51 patients. Neuroradiology. 2017. PMID: 28255904. doi:10.1007/s00234-017-1783-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。